Monoclonal Antibodies Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Monoclonal Antibodies stocks.

Monoclonal Antibodies Stocks Recent News

Date Stock Title
Oct 4 BGNE Chinese biotechs gain as drugmakers targeted in new security bill said to mull divestments
Oct 4 APGE Wellington Management Group LLP Increases Stake in Apogee Therapeutics Inc
Oct 4 BCAB BioAtla Announces Upcoming Poster Presentation at the 39th Society for Immunotherapy of Cancer Annual Meeting
Oct 3 BDX Becton Dickinson in pact to to resolve vast majority of hernia litigation
Oct 3 BDX Becton Dickinson to pay over $1B to settle hernia litigation: report
Oct 3 BDX Three Reasons Why You Should Hold BDX Stock in Your Portfolio Now
Oct 3 HALO Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE®
Oct 2 BDX Becton Dickinson settles bulk of outstanding hernia litigation
Oct 2 BDX BD Reaches Agreement to Resolve Vast Majority of Hernia Litigation
Oct 2 RCUS Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
Oct 2 HALO High Growth Tech Stocks In The United States To Watch
Oct 2 BDX Becton Dickinson target raised, added to ‘Tactical Outperform’ list at Evercore
Oct 1 BDX BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch
Oct 1 HALO Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Oct 1 BCAB BioAtla Announces Upcoming Oral Presentation at the Society for Melanoma Research 21st International Congress
Sep 30 MRUS Merus Announces First Patient Dosed in LiGeR-HN1, a Phase 3 Trial Evaluating Petosemtamab in Combination with Pembrolizumab in 1L r/m HNSCC
Monoclonal Antibodies

Monoclonal antibodies (mAb or moAb) are antibodies that are made by identical immune cells that are all clones of a unique parent cell. Monoclonal antibodies can have monovalent affinity, in that they bind to the same epitope (the part of an antigen that is recognized by the antibody). In contrast, polyclonal antibodies bind to multiple epitopes and are usually made by several different plasma cell (antibody secreting immune cell) lineages. Bispecific monoclonal antibodies can also be engineered, by increasing the therapeutic targets of one single monoclonal antibody to two epitopes.

Browse All Tags